Loading...

OTC Markets

Totals

Securities

12,306

Dollar Vol

$2.0B

Share Vol

Trades

367,183

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

Market Activity
Stock
TGRP
Company Profile

TGRP
TRON Group Inc.

Common Stock

0.0496

0.0231

87.17%

0.0283 / 0.0487 (1 x 1)

Real-Time Best Bid & Ask: 05:00pm 07/11/2025

Delayed (15 Min) Trade Data: 12:00am 07/11/2025

14120 NW 126 Terrace

Alachua, FL 32615

Principal Executive Offices:

14120 NW 126 Terrace

Alachua, FL 32615

www.tron-group.com

+1 386-401-6304

info@nanopharmaceutics.com

Business Description

TRON Group Inc. (OTC: TGRP), through its subsidiaries, is a clinical-stage specialty pharmaceutical company developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, diabetes and infectious diseases. TRON Group Inc. subsidiaries include Nanopharmaceutics, Inc., a wholly-owned subsidiary, and Alchem Laboratories Corporation, a majority-owned subsidiary, both located in Alachua, Florida.

Financial Reporting

Reporting Status

Alternative Reporting Standard

Audited Financials

Unaudited

Latest Report

03/31/2025 Quarterly Report

CIK

0001658605

Fiscal Year End

12/31

Company Officers & Contacts

James David Talton

President, CEO, Secretary

Judy C Talton

Acting CFO

Judy Talton is the Chief Clinical Officer and accountant for Nanopharmaceutics, Inc.

Board of Directors

Christopher John Deigl

Compensation Committee Member, Nominating Committee Member

George Lawson Fails

Compensation Committee Member, Nominating Committee Member

Gideon Shapiro

Independent Director, Audit Committee Member, Nominating Committee Member

James David Talton

Audit Committee Member, Compensation Committee Member, Nominating Committee Member

Jeffrey Scott Thinschmidt

Independent Director, Audit Committee Member, Compensation Committee Member

Stefan Vasile

Compensation Committee Member, Nominating Committee Member

Other Company Insiders

James Talton

Nanosphere Holdings LLC

James Talton

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.

Service Providers

Accounting/Auditing Firm

James Moore & Co.

5931 NW 1st Place

Gainesville, FL 32607

Securities Counsel

Law Offices of Mont E. Tanner

2950 East Flamingo Road

Suite G

Las Vegas, NV 89121-508

Profile Data

SIC - Industry Classification

8731 - Commercial physical research

Incorporation Information

NV, US, 2015

Employees

20 as of 06/06/2024

Shell

Products and Services

Nanopharmaceutics, Inc. is a clinical-stage specialty pharmaceutical company developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, diabetes and infectious diseases. Alchem Laboratories Corporation performs discovery, development, and manufacturing of preclinical to clinical stage pharmaceutical programs.

Company Facilities

14120 NW 126 Terrace Alachua, FL 32615

Company Notes

Formerly=Plush Corp until 12-2016